Dexmedetomidine-esketamine Combined Nasal Administration and Emergence Delirium

NCT06566469 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
340
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University First Hospital